NCT02090465View on ClinicalTrials.gov

Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks

CompletedOBSERVATIONAL
Enrollment

840

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Actinic Keratosis
Interventions
DRUG

Ingenol Mebutate

No intervention: observation of routine use of Picato®

Trial Locations (1)

D-69115

Universitätsklinikum Heidelberg/Klinische Sozialmedizin, Heidelberg

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY